| Bladder and Urothelial Cancer Treatments | Lifetime | 17 | CA 1 | 99.83 |
| Urinary and Genital Oncology Studies | Lifetime | 12 | CA 1 | 99.84 |
| Urological Disorders and Treatments | Lifetime | 31 | CA 1 | 99.71 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 41 | CA 4 | 99.81 |
| Prostate Cancer Treatment and Research | Lifetime | 72 | CA 8 | 99.71 |
| Urologic and reproductive health conditions | Lifetime | 101 | CA 5 | 99.30 |
| Cancer, Lipids, and Metabolism | Lifetime | 221 | CA 13 | 99.06 |
| Multiple and Secondary Primary Cancers | Lifetime | 141 | CA 4 | 98.27 |
| Esophageal Cancer Research and Treatment | Lifetime | 275 | CA 7 | 98.40 |
| Renal cell carcinoma treatment | Lifetime | 379 | CA 18 | 98.30 |
| Colorectal Cancer Screening and Detection | Lifetime | 464 | CA 11 | 98.24 |
| Genital Health and Disease | Lifetime | 345 | CA 14 | 97.10 |
| Hormonal and reproductive studies | Lifetime | 949 | CA 45 | 96.05 |
| Global Cancer Incidence and Screening | Lifetime | 976 | CA 45 | 96.14 |
| Statistical Methods in Clinical Trials | Lifetime | 525 | CA 37 | 94.47 |
| Sexual function and dysfunction studies | Lifetime | 644 | CA 41 | 94.47 |
| Infectious Disease Case Reports and Treatments | Lifetime | 99 | CA 5 | 91.71 |
| Prostate Cancer Diagnosis and Treatment | 2021-2025 | 57 | CA 3 | 99.05 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 79 | CA 3 | 98.83 |
| Prostate Cancer Treatment and Research | 2021-2025 | 101 | CA 3 | 98.83 |
| Urological Disorders and Treatments | 2021-2025 | 62 | CA 5 | 97.70 |
| Urinary and Genital Oncology Studies | 2021-2025 | 64 | CA 3 | 98.18 |
| Urologic and reproductive health conditions | 2021-2025 | 104 | CA 3 | 93.48 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 132 | CA 4 | 89.05 |
| Renal cell carcinoma treatment | 2021-2025 | 528 | CA 16 | 92.67 |
| Genital Health and Disease | 2021-2025 | 277 | CA 8 | 86.76 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 990 | CA 21 | 83.35 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 589 | CA 5 | 78.72 |
| Hormonal and reproductive studies | 2021-2025 | 754 | CA 17 | 77.18 |
| Infectious Disease Case Reports and Treatments | 2021-2025 | 48 | CA 1 | 71.91 |
| Adrenal and Paraganglionic Tumors | 2021-2025 | 934 | CA 17 | 75.32 |
| Testicular diseases and treatments | 2021-2025 | 575 | CA 25 | 69.16 |
